Affimed N.V.
AFMDNASDAQHealthcare
$0.18
+$0.00(+0.00%)
Market Cap$2975612
P/E Ratio—
52W High$8.95
52W Low$0.018
Affimed N.V. (AFMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AFMD · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: Jun 11, 2025EPS Actual
-$1.38
Est. -$0.52 · -165.4%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Jun 11, 2025
After Market Close
▼ Miss EPS
AFMD reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Nov 12, 2025 | — | — | — | — | — | — |
| ▼ Q2 FY2025 | Jun 11, 2025 | -$0.52 | -$1.38 | -165.4% | — | $0.00B | — |
| — Q2 FY2025 | May 28, 2025 | -$0.86 | -$0.87 | -0.5% | $0.00B | $0.00B | +75.0% |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$0.91 | -$0.87 | +4.4% | $0.00B | $0.00B | +49.2% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$1.14 | -$1.03 | +9.7% | $0.00B | $0.00B | -3.3% |
| ▼ Q3 FY2024 | Sep 5, 2024 | -$1.00 | -$1.09 | -9.0% | $0.00B | $0.00B | -92.4% |
| ▲ Q2 FY2024 | Jun 12, 2024 | -$1.73 | -$1.38 | +20.2% | $0.00B | $0.00B | -87.6% |
| ▲ Q1 FY2024 | Mar 28, 2024 | -$1.54 | -$1.35 | +12.3% | $0.00B | $0.00B | -73.3% |
Q4 FY2025
Nov 12, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 11, 2025Miss
EPS Actual
-$1.38
EPS Est.
-$0.52
EPS Surpr.
-165.4%
Revenue
—
Q2 FY2025
May 28, 2025
EPS Actual
-$0.87
EPS Est.
-$0.86
EPS Surpr.
-0.5%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.87
EPS Est.
-$0.91
EPS Surpr.
+4.4%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$1.03
EPS Est.
-$1.14
EPS Surpr.
+9.7%
Revenue
$0.00B
Q3 FY2024
Sep 5, 2024Miss
EPS Actual
-$1.09
EPS Est.
-$1.00
EPS Surpr.
-9.0%
Revenue
$0.00B
Q2 FY2024
Jun 12, 2024Beat
EPS Actual
-$1.38
EPS Est.
-$1.73
EPS Surpr.
+20.2%
Revenue
$0.00B
Q1 FY2024
Mar 28, 2024Beat
EPS Actual
-$1.35
EPS Est.
-$1.54
EPS Surpr.
+12.3%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q3 FY2026 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q2 FY2026 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q1 FY2026 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q4 FY2025 | $-0.42 | $-0.42 | $-0.42 | 1 |
| Q3 FY2025 | $-0.47 | $-0.47 | $-0.47 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2025 | Jun 11, 2025 | -165.4% | $0.08 | $0.07 | -15.00% |
| ▲ Q2 FY2025 | May 28, 2025 | -0.5% | $0.02 | $0.03 | +42.18% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +4.4% | $0.83 | $0.81 | -2.84% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +9.7% | $3.75 | $3.65 | -2.67% |
| ▼ Q3 FY2024 | Sep 5, 2024 | -9.0% | $3.75 | $3.79 | +1.07% |
| ▲ Q2 FY2024 | Jun 12, 2024 | +20.2% | $6.53 | $6.86 | +5.05% |
| ▲ Q1 FY2024 | Mar 28, 2024 | +12.3% | $5.33 | $5.30 | -0.56% |
| ▲ Q4 FY2023 | Nov 14, 2023 | +19.1% | $3.28 | $3.18 | -3.05% |
Q2 FY2025-15.00%
Report Date
Jun 11, 2025
EPS Beat/Miss
-165.4%
Price Before
$0.08
Price After
$0.07
Q2 FY2025+42.18%
Report Date
May 28, 2025
EPS Beat/Miss
-0.5%
Price Before
$0.02
Price After
$0.03
Q1 FY2025-2.84%
Report Date
Mar 27, 2025
EPS Beat/Miss
+4.4%
Price Before
$0.83
Price After
$0.81
Q4 FY2024-2.67%
Report Date
Nov 14, 2024
EPS Beat/Miss
+9.7%
Price Before
$3.75
Price After
$3.65
Q3 FY2024+1.07%
Report Date
Sep 5, 2024
EPS Beat/Miss
-9.0%
Price Before
$3.75
Price After
$3.79
Q2 FY2024+5.05%
Report Date
Jun 12, 2024
EPS Beat/Miss
+20.2%
Price Before
$6.53
Price After
$6.86
Q1 FY2024-0.56%
Report Date
Mar 28, 2024
EPS Beat/Miss
+12.3%
Price Before
$5.33
Price After
$5.30
Q4 FY2023-3.05%
Report Date
Nov 14, 2023
EPS Beat/Miss
+19.1%
Price Before
$3.28
Price After
$3.18
Avg Beat Reaction+6.35%
Avg Miss Reaction-6.96%
Beat Rate6 / 8 quarters
Largest Move+42.18% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AFMD ends December
Affimed N.V. (AFMD) most recently reported earnings on June 11, 2025 for Q2 FY2025, posting EPS of $-1.38 — missing the analyst consensus of $-0.52 by -165.4%. The next AFMD earnings date is expected around September 1, 2026.
Each quarter, investors track AFMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AFMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AFMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AFMD earnings · 5 questionsAffimed N.V.'s next earnings report is expected around September 1, 2026. AFMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AFMD historically reports after market close (AMC).
AFMD earnings datewhen is AFMD earningsAFMD next earnings datewhen does AFMD report earningsAFMD earnings calendar
▸ Source: FMP · Affimed N.V. SEC filings · US GAAP · Affimed N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026